Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12427151
Compositions and method of treating cancer
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12421525
Conjugates comprising AAVs and CAS9 polypeptides
granted -
US 12421302
CAR-t cells and autoimmune diseases
granted -
US 12419866
Compounds and methods for treating an epileptic disorder
granted -
US 12421517
Genetic modification of mammalian cells to confer resistance to CSF1R antagonists
granted -
US 12414999
Compositions and methods relating to macrophages and/or monocytes with adhered particles
granted -
US 12415843
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer
granted -
US 12409181
Treatment for aortic aneurysms
granted -
US 12410399
Compositions and methods for treating retinal diseases
granted -
US 12409220
Conjugate polypeptides and vaccines for inducing immune responses
granted -
US 12410398
Methods of human retinal progenitor cell isolation and culture
granted -
US 12404243
Inhibitors of the Wnt/beta-catenin pathway
granted -
US 12403202
Dosage of claudin-6 conjugates for cancer treatment
granted -
US 12396949
Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom
granted -
US 12398193
Targeted replacement of endogenous T cell receptors
granted -
US 12390473
Methods of treating tyrosine kinase inhibitor-induced diarrhea
granted -
US 12391643
Substituted amino-thiol and amino-disulfide compounds, and uses thereof
granted -
US 12391669
Substituted pyrimidines as IRE1 kinase inhibitors
granted -
US 12391654
CFTR regulators and methods of use thereof
granted